Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report

Although statins are generally well-tolerated, recent reports have linked their use to autoimmune liver disease. We present the case of a 70-year-old woman who developed hepatocellular injury 4 months after switching from simvastatin to high-intensity atorvastatin. Discontinuation of atorvastatin le...

Full description

Saved in:
Bibliographic Details
Main Authors: Khadijat-Ul-Kurba Hashim, Zuhra Hamzah, Ummul Afilah Omar, Nurwahyuna Rosli
Format: Article
Language:English
Published: Academy of Family Physicians of Malaysia 2025-06-01
Series:Malaysian Family Physician
Subjects:
Online Access:https://e-mfp.org/wp-content/uploads/20.34_13Jun2025.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839612890229768192
author Khadijat-Ul-Kurba Hashim
Zuhra Hamzah
Ummul Afilah Omar
Nurwahyuna Rosli
author_facet Khadijat-Ul-Kurba Hashim
Zuhra Hamzah
Ummul Afilah Omar
Nurwahyuna Rosli
author_sort Khadijat-Ul-Kurba Hashim
collection DOAJ
description Although statins are generally well-tolerated, recent reports have linked their use to autoimmune liver disease. We present the case of a 70-year-old woman who developed hepatocellular injury 4 months after switching from simvastatin to high-intensity atorvastatin. Discontinuation of atorvastatin led to a gradual improvement in liver function over 3 months; however, her rising LDL(low-density lipoprotein) levels prompted a rechallenge with simvastatin, resulting in recurrent liver function derangement. Despite cessation, the liver enzyme levels continued to rise. Positive autoantibodies, including antinuclear antibodies, anti-mitochondrial M2 and immunoglobulins (i.e. IgA and IgG), along with a liver biopsy, confirmed an overlapping syndrome of primary biliary cholangitis and autoimmune hepatitis. Treatment with prednisolone led to normalisation of liver function, and the patient remained stable on azathioprine and ursodeoxycholic acid. This case underscores the importance of vigilant liver function monitoring, caution when rechallenging statins and the potential for statin therapy to unmask underlying autoimmune liver disease.
format Article
id doaj-art-b21c7914d6f94281a8dba0a05fd283be
institution Matheson Library
issn 1985-2274
language English
publishDate 2025-06-01
publisher Academy of Family Physicians of Malaysia
record_format Article
series Malaysian Family Physician
spelling doaj-art-b21c7914d6f94281a8dba0a05fd283be2025-07-27T15:25:32ZengAcademy of Family Physicians of MalaysiaMalaysian Family Physician1985-22742025-06-01203410.51866/cr.853Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case reportKhadijat-Ul-Kurba HashimZuhra HamzahUmmul Afilah OmarNurwahyuna RosliAlthough statins are generally well-tolerated, recent reports have linked their use to autoimmune liver disease. We present the case of a 70-year-old woman who developed hepatocellular injury 4 months after switching from simvastatin to high-intensity atorvastatin. Discontinuation of atorvastatin led to a gradual improvement in liver function over 3 months; however, her rising LDL(low-density lipoprotein) levels prompted a rechallenge with simvastatin, resulting in recurrent liver function derangement. Despite cessation, the liver enzyme levels continued to rise. Positive autoantibodies, including antinuclear antibodies, anti-mitochondrial M2 and immunoglobulins (i.e. IgA and IgG), along with a liver biopsy, confirmed an overlapping syndrome of primary biliary cholangitis and autoimmune hepatitis. Treatment with prednisolone led to normalisation of liver function, and the patient remained stable on azathioprine and ursodeoxycholic acid. This case underscores the importance of vigilant liver function monitoring, caution when rechallenging statins and the potential for statin therapy to unmask underlying autoimmune liver disease.https://e-mfp.org/wp-content/uploads/20.34_13Jun2025.pdfatorvastatinprimary biliary cholangitis (pbc)autoimmune hepatitis (aih)liver diseaseautoimmune
spellingShingle Khadijat-Ul-Kurba Hashim
Zuhra Hamzah
Ummul Afilah Omar
Nurwahyuna Rosli
Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report
Malaysian Family Physician
atorvastatin
primary biliary cholangitis (pbc)
autoimmune hepatitis (aih)
liver disease
autoimmune
title Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report
title_full Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report
title_fullStr Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report
title_full_unstemmed Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report
title_short Atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult: A case report
title_sort atorvastatin unveiling primary biliary cholangitis and autoimmune hepatitis overlap syndrome in an older adult a case report
topic atorvastatin
primary biliary cholangitis (pbc)
autoimmune hepatitis (aih)
liver disease
autoimmune
url https://e-mfp.org/wp-content/uploads/20.34_13Jun2025.pdf
work_keys_str_mv AT khadijatulkurbahashim atorvastatinunveilingprimarybiliarycholangitisandautoimmunehepatitisoverlapsyndromeinanolderadultacasereport
AT zuhrahamzah atorvastatinunveilingprimarybiliarycholangitisandautoimmunehepatitisoverlapsyndromeinanolderadultacasereport
AT ummulafilahomar atorvastatinunveilingprimarybiliarycholangitisandautoimmunehepatitisoverlapsyndromeinanolderadultacasereport
AT nurwahyunarosli atorvastatinunveilingprimarybiliarycholangitisandautoimmunehepatitisoverlapsyndromeinanolderadultacasereport